BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2677093)

  • 1. Modulation of Fc receptor clearance and antiplatelet antibodies as a consequence of intravenous immune globulin infusion in patients with immune thrombocytopenic purpura.
    Bussel JB
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):566-77; discussion 577-8. PubMed ID: 2677093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intravenous gamma-globulin in idiopathic thrombocytopenic purpura.
    Bussel JB
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S147-55. PubMed ID: 2477185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.
    Bussel JB; Graziano JN; Kimberly RP; Pahwa S; Aledort LM
    Blood; 1991 May; 77(9):1884-93. PubMed ID: 1850307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children.
    Warrier I; Lusher JM
    Am J Med; 1984 Mar; 76(3A):193-8. PubMed ID: 6424451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use and mechanism of action of intravenous immunoglobulin in the treatment of immune haematologic disease.
    Bussel JB; Hilgartner MW
    Br J Haematol; 1984 Jan; 56(1):1-7. PubMed ID: 6367804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults.
    Oral A; Nusbacher J; Hill JB; Lewis JH
    Am J Med; 1984 Mar; 76(3A):187-92. PubMed ID: 6424449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
    Mehta YS; Badakere SS
    J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody 197 (anti-Fc gamma RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc gamma RI on circulating monocytes.
    Ericson SG; Coleman KD; Wardwell K; Baker S; Fanger MW; Guyre PM; Ely P
    Br J Haematol; 1996 Mar; 92(3):718-24. PubMed ID: 8616043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fc receptor blockade and immune thrombocytopenic purpura.
    Bussel JB
    Semin Hematol; 2000 Jul; 37(3):261-6. PubMed ID: 10942220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous gammaglobulin on circulating and platelet-bound antibody in immune thrombocytopenia.
    Barbano G; Saleh MN; Mori PG; LoBuglio AF; Shaw DR
    Blood; 1989 Feb; 73(3):662-5. PubMed ID: 2465040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG.
    Ambriz-Fernández R; Martínez-Murillo C; Quintana-González S; Collazo-Jaloma J; Bautista-Juárez J
    Arch Med Res; 2002; 33(6):536-40. PubMed ID: 12505098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin bound to platelets as immune complexes or specific antibody in specimens from acquired immunodeficiency syndrome and immune thrombocytopenic purpura.
    Daugharty H; Chorba TL; Personette DW; Savoca KV; MacDonald V
    Diagn Immunol; 1985; 3(4):205-14. PubMed ID: 2935354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy between antiplatelet antibody activities detected by immunoblot procedure and platelet counts in idiopathic thrombocytopenic purpura.
    Matsumoto M; Takada K; Kameoka H; Hato T; Shiosaka T; Fujita S; Kobayashi Y
    Jpn J Med; 1991; 30(1):10-4. PubMed ID: 1865569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses.
    Etzioni A; Pollack S
    Autoimmunity; 1989; 3(4):307-15. PubMed ID: 2485083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet GPIIb/IIIa binding to fibrinogen by serum factors: studies of circulating immune complexes and platelet antibodies in patients with hemophilia, immune thrombocytopenic purpura, human immunodeficiency virus-related immune thrombocytopenic purpura, and systemic lupus erythematosus.
    Kamiyama M; Arkel YS; Chen K; Shido K
    J Lab Clin Med; 1991 Mar; 117(3):209-17. PubMed ID: 2002277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy in cytopenia.
    Bussell J
    Vox Sang; 1986; 51 Suppl 2():69-73. PubMed ID: 3765552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term response in a patient with ITP following low dose anti-D immunoglobulin therapy.
    Smith NA; Chakraverty RK; Obeid D; Boughton BJ
    Autoimmunity; 1989; 4(1-2):115-7. PubMed ID: 2562380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenic purpura and intravenous immunoglobulin.
    Imbach P
    Cancer; 1991 Sep; 68(6 Suppl):1422-5. PubMed ID: 1878840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune thrombocytopenic purpura. Use of a 125I-labeled antihuman IgG monoclonal antibody to quantify platelet-bound IgG.
    LoBuglio AF; Court WS; Vinocur L; Maglott G; Shaw GM
    N Engl J Med; 1983 Aug; 309(8):459-63. PubMed ID: 6683784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic thrombocytopenic purpura.
    Burns TR; Saleem A
    Am J Med; 1983 Dec; 75(6):1001-7. PubMed ID: 6685977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.